Concepedia

Wenlang Fu

WF

Statistics

Publications

4

Citations

286

H-Index

4

Active since

2007

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Wenlang Fu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and biochemistry.

Top concepts

Publications per year

2007–2014

4

Publications

4

Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity

Joachim Rudolph, William P. Esler, Stephen O’Connor et al. · Journal of Medicinal Chemistry · 2007 · 157 citations · Full text

, , +17

siRNA-optimized Modifications for Enhanced In Vivo Activity

Denise M. Kenski, Gabor Butora, Aarron Willingham et al. · Molecular Therapy — Nucleic Acids · 2012 · 89 citations · Full text

Cyclic‐Disulfide‐Based Prodrugs for Cytosol‐Specific Drug Delivery

Gabor Butora, Ning Qi, Wenlang Fu et al. · Angewandte Chemie International Edition · 2014 · 24 citations

, , +15

Nucleoside Optimization for RNAi: A High-Throughput Platform

Gabor Butora, Denise M. Kenski, Abby J. Cooper et al. · Journal of the American Chemical Society · 2011 · 16 citations

, , +13

1–4 of 4